Skip to main content
. 2014 Oct 2;33(1):83. doi: 10.1186/s13046-014-0083-8

Figure 4.

Figure 4

Overall survival analysis for patients according to tumor PTEN-status. A. in the whole population B. in the subgroup treated with adjuvant 5-FU/FA/irinotecan.